426 related articles for article (PubMed ID: 29886103)
1. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis.
Hanafy AS; Abd-Elsalam S; Dawoud MM
Vascul Pharmacol; 2019 Feb; 113():86-91. PubMed ID: 29886103
[TBL] [Abstract][Full Text] [Related]
2. Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban.
Yang H; Kim SR; Song MJ
Clin Mol Hepatol; 2016 Dec; 22(4):499-502. PubMed ID: 27880998
[TBL] [Abstract][Full Text] [Related]
3. Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis.
Diken AI; Yalçınkaya A; Hanedan MO; Erol ME; Ercen Diken Ö
Phlebology; 2018 Feb; 33(1):53-59. PubMed ID: 28056701
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
Lv Y; Bai W; Li K; Wang Z; Guo W; Luo B; Wang J; Wang Q; Wang E; Xia D; Li X; Yuan J; Han N; Niu J; Yin Z; Fan D; Han G
Am J Gastroenterol; 2021 Jul; 116(7):1447-1464. PubMed ID: 33630766
[TBL] [Abstract][Full Text] [Related]
5. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
Zhou H; Wu M; Yu S; Xia H; Yu W; Huang K; Chen Y
BMC Gastroenterol; 2023 Sep; 23(1):329. PubMed ID: 37749527
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Nadroparin Calcium-Warfarin Sequential Anticoagulation in Portal Vein Thrombosis in Cirrhotic Patients: A Randomized Controlled Trial.
Zhou T; Sun X; Zhou T; Li Y; Chen X; Cheng B; Gao Y
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00228. PubMed ID: 32858573
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B.
Cui SB; Shu RH; Yan SP; Wu H; Chen Y; Wang L; Zhu Q
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):914-9. PubMed ID: 25856686
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
10. Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin.
Houghton DE; Lekah A; Macedo TA; Hodge D; Saadiq RA; Little Y; Casanegra AI; McBane RD; Wysokinski WE
J Thromb Thrombolysis; 2020 Feb; 49(2):199-205. PubMed ID: 31422520
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Piazza G; Mani V; Goldhaber SZ; Grosso MA; Mercuri M; Lanz HJ; Schussler S; Hsu C; Chinigo A; Ritchie B; Nadar V; Cannon K; Pullman J; Concha M; Schul M; Fayad ZA;
Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
[TBL] [Abstract][Full Text] [Related]
12. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
[TBL] [Abstract][Full Text] [Related]
13. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.
Rodriguez-Castro KI; Vitale A; Fadin M; Shalaby S; Zerbinati P; Sartori MT; Landi S; Pettinari I; Piscaglia F; Han G; Burra P; Simioni P; Senzolo M
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):34-42. PubMed ID: 30188408
[TBL] [Abstract][Full Text] [Related]
14. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.
Gao Z; Li S; Zhao J; Li J; Gao Y
Intern Emerg Med; 2023 Mar; 18(2):513-521. PubMed ID: 36692588
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban.
Ferreira T; Huber SC; de Moraes Martinelli B; Junior AL; Menezes FH; Orsi FA; Bittar LF; de Oliveira LFG; Sodre LR; Mello TT; Rielli G; Colella MP; de Paula EV; Yamaguti-Hayakawa GG; Montalvão S; Annichino-Bizzacchi JM
Vascul Pharmacol; 2020 Jan; 124():106608. PubMed ID: 31678199
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
[TBL] [Abstract][Full Text] [Related]
19. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of rivaroxaban use in patients with gynecologic malignancies at an academic medical center: A pilot study.
Signorelli JR; Gandhi AS
J Oncol Pharm Pract; 2019 Mar; 25(2):362-368. PubMed ID: 29157146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]